RoActemra

Roche’s Actemra/RoActemra approved for treatment of severe COVID-19 in the EU
Biopharma Reporter
Tue, 12/7/21 - 11:04 am
Roche
Actemra
RoActemra
COVID-19
Europe
Further Studies Show Conflicting Results of Arthritis Drug for Severe COVID-19
BioSpace
Fri, 01/22/21 - 10:35 am
COVID-19
arthritis
Actemra
RoActemra
Roche
Roche’s tocilizumab fails to achieve primary endpoints for Covid-19-related pneumonia
Pharmaceutical Business Review
Thu, 07/30/20 - 10:59 am
Roche
Actemra
RoActemra
COVID-19
clinical trials
COVID-19 pneumonia
Roche and Gilead Launch COVID-19 Trial to Test One-Two Punch of Actemra and Remdesivir
BioSpace
Thu, 05/28/20 - 10:59 pm
Roche
Gilead Sciences
clinical trials
Actemra
RoActemra
remdesivir
COVID-19
pneumonia
COVID-19 pneumonia
Roche's RoACTEMRA To Go Up Against Anti-Rheumatoid Arthritis Drugs From Bristol-Myers, AbbVie
Bidness Etc.
Mon, 09/8/14 - 12:29 pm
Roche
rheumatoid arthritis
RoActemra
AbbVie
Bristol-Myers Squibb
Roche says arthritis drug beats top-selling rival in trial
Reuters
Wed, 06/6/12 - 10:45 am
RoActemra
Roche
rheumatoid arthritis
Abbott Laboratories
Humira
Roche Should Give More Data on RoActemra Drug, U.K.’s NICE Says
Bloomberg
Wed, 12/16/09 - 10:10 am
Roche
rheumatoid arthritis
UK
RoActemra